CRHvsIngevity

CRH and NGVT stock compared: price, dividend, valuation and results, from SEC filings.

CRH (CRH) has a market value of $60.5B and Ingevity (NGVT) $2.0B. Over the last year, with dividends, CRH moved -15.5% and NGVT +16.6%. The P/E is 17.0 for CRH and 33.0 for NGVT. Dividend yield: CRH 1.72%, NGVT none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CRH$60.5B

    NGVT$2.0B

    CRH is 31 times NGVT

  • Revenue, 12 months

    CRH$39.0B

    NGVT$1.1B

    CRH is 34 times NGVT

  • Net income, 12 months

    CRH$3.6B

    NGVT$60M

    CRH is 60 times NGVT

  • Operating margin

    CRH13.7%

    NGVT3.9%

    9.8 points apart

  • ROIC

    CRH9.2%

    NGVT2.8%

    6.4 points apart

  • P/E

    CRH17.0

    NGVT33.0

    NGVT is 1.9 times CRH

  • Dividend yield

    CRH1.7%

    NGVT0.0%

    1.7 points apart

  • 5-year return

    CRH+107.8%

    NGVT-28.6%

    136.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CRH+107.8%

NGVT-28.6%

10020030020222023202420252026
Returns by period
PeriodCRHWith dividendsNGVTWith dividends
1 year since November 18, 2025-15.5%Price -16.8%+16.6%Price +16.6%
3 years since November 17, 2023+58.9%+16.7% a yearPrice +50.4%+39.4%+11.7% a yearPrice +39.4%
5 years since November 18, 2021+107.8%+15.7% a yearPrice +81.8%-28.6%-6.5% a yearPrice -28.6%
10 years since November 21, 2016+248.8%+13.3% a yearPrice +168.6%+9.8%+0.9% a yearPrice +9.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CRHCRHNGVTIngevity

Valuation

CRHNGVT
Valuation
Price$90.54$55.96
Market value$60.5B$2.0B
Enterprise value (EV)$75.7B$3.0B
P/E17.033.0
P/E, 5-year median16.0–
P/B2.431.4
EV/EBIT14.268.2
Free cash flow yield4.2%6.2%

Results and growth

CRHNGVT
Results and growth
Revenue, 12 months$39.0B$1.1B
Net income, 12 months$3.6B$60M
Free cash flow, 12 months$2.5B$123M
Earnings per share, 12 months$5.32$1.73
Revenue growth, year on year5.3%-2.7%
Revenue growth a year, past+7.7%over 5 years-0.8%over 5 years
EPS growth a year, past-47.8%over 5 years–

Margins and returns on capital

CRHNGVT
Margins and returns on capital
Gross margin36.2%42.1%
Operating margin13.7%3.9%
Net margin9.2%5.3%
ROIC9.2%2.8%
ROE15.0%94.4%

Balance sheet

CRHNGVT
Balance sheet
Cash$5.1B$85M
Total debt$21.6B$1.2B
Net debt / EBITDA2.07.0
Interest cover6.3×0.6×

Dividends and buybacks

CRHNGVT
Dividends and buybacks
Dividend yield1.7%–
Dividend per share, 12 months$1.56–
Dividend growth a year, past––
Buyback yield2.0%2.9%
Shareholder yield3.7%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CRH or NGVT

Didn't find what you were looking for?

Ask us
Which is bigger, CRH or Ingevity?

By market value, CRH ($60.5B) is about 30.6 times Ingevity ($2.0B), at today's prices.

How did CRH and NGVT stock do over the last 10 years?

Since November 21, 2016, CRH's price moved +168.6% and NGVT's +9.8%. With dividends: CRH +248.8% (+13.3% a year), NGVT +9.8% (+0.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, CRH or NGVT?

The dividend yield at today's price is 1.72% for CRH and none for Ingevity. Over the last twelve months they paid $1.56 and – per share.

What is the P/E of CRH and NGVT?

At today's price, the P/E is 17.0 for CRH and 33.0 for NGVT. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, CRH or Ingevity?

Over the last twelve months, the net margin was 9.2% for CRH and 5.3% for Ingevity, and the operating margin 13.7% and 3.9%. Revenue was $39.0B and $1.1B.

Which is the better investment, CRH or Ingevity?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.